VolitionRX Ltd (VNRX) USD0.001

Sell:$0.51Buy:$0.55$0.00 (0.61%)

Prices delayed by at least 15 minutes
Sell:$0.51
Buy:$0.55
Change:$0.00 (0.61%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.51
Buy:$0.55
Change:$0.00 (0.61%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Key people

Cameron John Reynolds
President, Chief Executive Officer, Director
Terig Hughes
Chief Financial Officer, Treasurer
Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Jasmine Kway
Chief Executive Officer of Singapore Volition
Gaetan Michel
Chief Operating Officer
Louise Batchelor
Group Chief Marketing and Communications Officer
Jacob Vincent Micallef
Chief Scientific Officer
Nicholas Plummer
Group General Counsel
Gael Forterre
Chief Commercial Officer
Andrew Retter
Chief Medical Officer
Timothy I. Still
Non-Executive Chairman of the Board
Phillip Barnes
Independent Director
Alan Colman
Independent Director
Mickie Henshall
Independent Director
Guy Archibald Innes
Independent Director
Click to see more

Key facts

  • EPIC
    VNRX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US9286611077
  • Market cap
    $46.32m
  • Employees
    85
  • Shares in issue
    96.50m
  • Exchange
    Nyse American LLC
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.